日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study

III期和IV期黑色素瘤抗PD-1免疫疗法耐药性:一项全球病例回顾研究

Gaughan, Elizabeth M; Kim, Miso; Mendez, Ignacio; Rao, Aparna D; Wei, Maria; So, Alexandra; Zhong, Xiaochen; Berking, Carola; Jiang, Ruixuan; Kim, Tae Min; Dalle, Stéphane; Robert, Caroline; Danson, Sarah; Alam, Salma; Charles, Julie; Davies, Tessa; Debus, Dirk; Dzienis, Marcin; Frazer, Ricky; Gebhardt, Christoffer; Geidel, Glenn; Hassel, Jessica C; Hansen, Inga; Heppt, Markus Vincent; Hildebrandt, Lina; Isaacs, James M; Suh, Koung Jin; Keam, Bhumsuk; Kim, Yu Jung; Lesimple, Thierry; Saiag, Philippe; Delibes, Alicia; Barnett, Rosemarie; Krepler, Clemens; Gandhi, Kavita; Qizilbash, Nawab; Shui, Irene M; Tan, Xiang-Lin; Sullivan, Ryan J

Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status

卡博替尼与安慰剂治疗既往接受过血管内皮生长因子受体靶向治疗的放射性碘难治性分化型甲状腺癌患者(COSMIC-311):按BRAF状态分析的疗效

Brose, Marcia S; Keam, Bhumsuk; Krajewska, Jolanta; Hoff, Ana O; Vaisman, Fernanda; Lin, Chia-Chi; Hitre, Erika; Bowles, Daniel W; Robinson, Bruce; Sherman, Steven I; Ngamphaiboon, Nuttapong; Guo, Xiang; Simmons, Andrew; Williamson, Denise; Andrianova, Svetlana; Berry, Nicholas; Capdevila, Jaume

Clinical Characteristics Associated with High [(68)Ga]Ga-PSMA-11 Uptake and Preliminary Therapeutic Outcomes in Patients with Metastatic Adenoid Cystic Carcinoma

转移性腺样囊性癌患者中与高[(68)Ga]Ga-PSMA-11摄取相关的临床特征及初步治疗结果

Sung, Hyunpil; Suh, Minseok; Gil, Joonhyung; Keam, Bhumsuk; Cheon, Gi Jeong; Kang, Keon Wook

Barriers and facilitators of tuberculosis treatment adherence among nomadic populations in Sub-Saharan Africa: A scoping review protocol

影响撒哈拉以南非洲游牧人群结核病治疗依从性的障碍和促进因素:范围界定综述方案

Troop, Pablo; Keam, Brenna; Mullen, Caroline; Odhiambo, Julius Nyerere

Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer.

在 PD-L1 高表达的肺癌中,细胞内在的 PD-L1 信号通过 IL-6/Jak/Stat3 途径驱动髓系来源的抑制细胞发挥免疫抑制作用

Jeong Hyein, Koh Jaemoon, Kim Sehui, Yim Jeemin, Song Seung Geun, Kim Hanbyeol, Li Yingying, Lee Soo Hyun, Chung Yeon Kyu, Kim Hongsoon, Lee Chul-Hwan, Kim Hye Young, Keam Bhumsuk, Lee Se-Hoon, Chung Doo Hyun, Jeon Yoon Kyung

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INTERLINK-1:一项评估莫那珠单抗联合西妥昔单抗治疗复发/转移性头颈部鳞状细胞癌的III期随机、安慰剂对照研究

Fayette, Jérôme; Licitra, Lisa; Harrington, Kevin; Haddad, Robert; Siu, Lillian L; Liu, Yi-Chun; Tahara, Makoto; Machiels, Jean-Pascal; Rischin, Danny; Seiwert, Tanguy Y; Ferris, Robert L; Keilholz, Ulrich; Psyrri, Amanda; Keam, Bhumsuk; Bossi, Paolo; Metcalf, Robert; Hsieh, Ching-Yun; Clement, Paul M J; Isaev, Pavel; Mudunov, Ali; Dinis, José; Hoeben, Ann; Kasper, Stefan; Klinghammer, Konrad; Hwang, Michael; Blando, Jorge; Serrano, Olivier; Ruscica, Dario; Cohen, Roger B

Broad-Spectrum Antibiotic Use at the End of Life in Patients With Advanced Cancer

晚期癌症患者临终时使用广谱抗生素

Kim, Jeong-Han; Yu, Jiwon; Yoo, Shin Hye; Sim, Jin-Ah; Keam, Bhumsuk; Heo, Dae Seog

Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications

内膜肉瘤的基因组分析揭示了具有不同肿瘤微环境和治疗意义的分子亚型。

Park, C; Kim, R; Bae, J M; Lee, T; Song, S; Kwak, Y; Lee, K B; Youk, J; Keam, B; Kim, T M; Kim, D-W; Kim, J-I; Choi, J; Kim, M

Quality-of-care indicators for oncology management: an analysis of Asia-Pacific healthcare and oncology indicators

肿瘤管理质量指标:亚太地区医疗保健和肿瘤指标分析

Kanesvaran, R; Wong, E Y T; Keam, B; Prasongsook, N; Malhotra, H; Blay, J-Y

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)

在一项伞状试验中识别头颈部鳞状细胞癌的预测标志物(KCSG HN 15-16 TRIUMPH 试验)

S Hwang ,M H Hong ,S H Shin ,T Yun ,K-W Lee ,J H Kim ,M J Ahn ,B Keam ,H W Lee ,M K Kim ,H J Yun ,Y Kim ,H J Kim ,S H Cho ,H J An ,S Y Oh ,S-G Park ,Y W Koh ,H K Ahn ,J H Kwon ,Y-G Lee ,K-U Park ,I G Hwang ,S-B Kim ,S Kim ,H R Kim